Stay updated with breaking news from Untitled Letters. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On May 21, 2024, the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) published a warning letter issued to Akan Biosciences, Inc.
On December 26, 2023, the Food and Drug Administration’s Office of Prescription Drug Promotion (“OPDP”) issued a Questions and Answers Guidance for industry titled “Direct-to-Consumer...
The year 2023 was a busy one for regulatory, compliance, and enforcement developments in the healthcare and life sciences industries, and 2024 promises to be even busier. We tapped...
The year 2023 was a busy one for regulatory, compliance, and enforcement developments in the healthcare and life sciences industries, and 2024…
Center for Biologics Evaluation and Research and Food and Drug Administration FDA publish warning letter to Akan Biosciences for unresolved inspection observation